ISF/ESCMID Sepsis Award

2023 recipient of ISF-ESCMID Sepsis Award

Prof. Dr. Claire Dahyot-Fizelier


Prof. Dr. Claire Dahyot-Fizelier (female, born in 1972, French) is a professor in Anesthesia and Intensive Care at the faculty of Medicine of Poitiers’ University since 2016. She studied Medicine in Caen then Anesthesia and Intensive Care in Poitiers, obtained her Ph.D. in March 2008, became Assistant Professor in 2009 and Professor in 2016 at the University of Poitiers.


Claire Dahyot-Fizelier has been practicing Anesthesia-Intensive Care since 2005 at the Poitiers’ University Hospital of Poitiers, and since 2012 has been working exclusively in intensive care. Her field of expertise is neuro-intensive care and in 2012, she became head of Neuro-Intensive Care Unit at the University Hospital of Poitiers.


For 15 years, Claire Dahyot-Fizelier has been a member of the INSERM U1070 Research unit called « Pharmacology of antimicrobial agents and antibioResistance», a multidisciplinary group working on antibiotics  PK-PD with translational approaches to the pharmacokinetic-pharmacodynamic of antimicrobial agents in critically ill patients. Thus, her main research interest is prevention and optimization of antimicrobial treatment in severe infections. Claire Dahyot-Fizelier began her research in studying antibiotics tissue distribution using microdialysis in the lung and muscle tissue of animals. Then, sheShe then developed research using microdialysis in a clinical setting in different tissues (muscle, peritoneal cavity and brain) of critically ill patients, in. muscle, peritoneal cavity and brain.


Within the U1070 research team, she now focuses her research on the PK-PD of antimicrobial in the central nervous system in extracellular fluids and cerebro-spinal fluid, as well as leading a French multicenter study on this topic, the PKpopLCR trial.


Claire Dahyot-Fizelier is also a member of the board of the ATLANREA research network, that has been working for a decade on the population of severely brain injured patients. The ATLANREA research network has already published several multicenter studies on ventilator-associated pneumonia, and PROPHY-VAP trial is one of the group’s projects. Claire Dahyot-Fizelier is also a member of the EBIC (European Brain Injury Consortium) and ESGIB (ESCMID Study Group for Infectious Diseases of the Brain); treasurer of the ANARLF (Association de Neuro-Anesthésie Réanimation de langue Française); and President of the Intensive care Committee of SFAR, the French Society of Anesthesia and Intensive Care.